Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com
AF and PCI in Practice. - ppt download
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology
ENTRUST AF PCI
Davide Capodanno on Twitter: "ENTRUST-AF PCI completes the series of trials of NOAC-DAT vs VKA-TAT. If you want to read more, here is our commentary for The Lancet. https://t.co/326DTeHpiM https://t.co/TXliAi2lAq" / Twitter
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal
Antithrombotic treatment strategies after PCI – Authors' reply - The Lancet
Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology
Atrial Fibrillation and PCI - ppt download
AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups | tctmd.com
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI
Antithrombotic Therapy in AF Patients Undergoing PCI - ppt download
Antithrombotic Therapy in AF Patients Undergoing PCI - ppt download
Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis | SpringerLink
Role and Timing of Aspirin Therapy Following PCI in Patients With Atrial Fibrillation - American Journal of Cardiology
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies - Atherosclerosis
ENTRUST AF PCI
Francesco Costa
دفع ساخر ترجمة entrust af pci ppt - snssri.org
